choline has been researched along with paclitaxel in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Baek, HM; Bahri, S; Chen, JH; Mehta, RS; Nalcioglu, O; Nie, K; Su, MY; Yu, HJ | 1 |
| Brenton, JD; Crawford, RA; Earl, HM; Gill, AB; Graves, MJ; Griffiths, JR; Hodgkin, C; Jimenez-Linan, M; Joubert, I; Kataoka, MY; Lomas, DJ; McLean, MA; Priest, AN; Sala, E | 1 |
| Bagnoli, M; Canevari, S; De Cecco, L; Granata, A; Iorio, E; Mezzanzanica, D; Nicoletti, R; Pisanu, ME; Podo, F; Ricci, A; Tinaglia, V | 1 |
| Alzyoud, KS; Phyu, SM; Smith, TAD; Tseng, CC | 1 |
5 other study(ies) available for choline and paclitaxel
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Choline; Contrast Media; Cyclophosphamide; Doxorubicin; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Middle Aged; Neoadjuvant Therapy; Paclitaxel; ROC Curve; Statistics, Nonparametric; Trastuzumab; Treatment Outcome | 2009 |
Advanced ovarian cancer: multiparametric MR imaging demonstrates response- and metastasis-specific effects.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Area Under Curve; Biomarkers, Tumor; CA-125 Antigen; Carboplatin; Choline; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Spectroscopy; Middle Aged; Organometallic Compounds; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Prospective Studies; Statistics, Nonparametric; Tomography, X-Ray Computed | 2012 |
Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer.
Topics: Carcinoma, Ovarian Epithelial; Cell Death; Cell Line, Tumor; Cell Movement; Cell Proliferation; Choline; Choline Kinase; Down-Regulation; Doxorubicin; Female; Humans; Lipid Metabolism; Molecular Targeted Therapy; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Phosphorylcholine; Platinum; RNA Interference; Signal Transduction; Transcriptome | 2014 |
Response Detection of Castrate-Resistant Prostate Cancer to Clinically Utilised and Novel Treatments by Monitoring Phospholipid Metabolism.
Topics: Cell Line, Tumor; Cell Proliferation; Choline; Flutamide; Humans; Male; Paclitaxel; Phospholipids; Phosphorylation; Propane; Prostatic Neoplasms, Castration-Resistant; Proton Magnetic Resonance Spectroscopy; Treatment Outcome; Tritium | 2017 |